• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结石基质中的硫酸肝素及其对草酸钙结晶的抑制作用。

Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.

作者信息

Yamaguchi S, Yoshioka T, Utsunomiya M, Koide T, Osafune M, Okuyama A, Sonoda T

机构信息

Department of Urology, Osaka University Medical School, Japan.

出版信息

Urol Res. 1993 May;21(3):187-92. doi: 10.1007/BF00590035.

DOI:10.1007/BF00590035
PMID:8342253
Abstract

The nature of the soluble stone matrix and its possible role in urinary stone formation was studied. For this purpose we performed two-dimensional cellulose acetate membrane electrophoresis of the glycosaminoglycans (GAGs) which were contained in the soluble stone matrix, substances adsorbed onto calcium oxalate crystals in vitro (crystal surface binding substances, CSBS) and urinary macromolecules (UMMs). The main GAG in the soluble stone matrix and CSBS was found to be heparan sulfate, whereas the UMMs contained various GAGs usually seen in urine. An inhibition assay showed the soluble stone matrix to have the strongest inhibitory activity among these macromolecular substances when inhibitory activity was expressed in terms of uronic acid concentration. It is suggested that the main GAG in the soluble stone matrix consists of heparan sulfate, which has a strong inhibitory activity on calcium oxalate crystal growth and aggregation and constitutes part of the CSBS.

摘要

研究了可溶性结石基质的性质及其在尿路结石形成中的可能作用。为此,我们对可溶性结石基质中所含的糖胺聚糖(GAGs)、体外吸附在草酸钙晶体上的物质(晶体表面结合物质,CSBS)和尿大分子(UMMs)进行了二维醋酸纤维素膜电泳。结果发现,可溶性结石基质和CSBS中的主要GAG是硫酸乙酰肝素,而UMMs则含有尿液中常见的各种GAG。抑制试验表明,当以糖醛酸浓度表示抑制活性时,可溶性结石基质在这些大分子物质中具有最强的抑制活性。提示可溶性结石基质中的主要GAG由硫酸乙酰肝素组成,其对草酸钙晶体的生长和聚集具有较强的抑制活性,并构成CSBS的一部分。

相似文献

1
Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.结石基质中的硫酸肝素及其对草酸钙结晶的抑制作用。
Urol Res. 1993 May;21(3):187-92. doi: 10.1007/BF00590035.
2
Urinary crystal surface binding substances on calcium oxalate crystals.草酸钙晶体上的尿液晶体表面结合物质。
Urol Res. 1990;18(6):387-92. doi: 10.1007/BF00297370.
3
Glycosaminoglycans content of stone matrix.结石基质的糖胺聚糖含量
J Urol. 1986 May;135(5):1078-83. doi: 10.1016/s0022-5347(17)45979-9.
4
Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.硫酸软骨素和硫酸乙酰肝素对草酸钙结晶的单独作用:结石形成者与正常对照受试者之间的差异
Clin Sci (Lond). 1993 Jul;85(1):33-9. doi: 10.1042/cs0850033.
5
[Inhibitory factors of calcium oxalate crystal growth in urinary macromolecules].[尿中大分子物质对草酸钙晶体生长的抑制因子]
Nihon Hinyokika Gakkai Zasshi. 1990 Jun;81(6):883-8. doi: 10.5980/jpnjurol1989.81.883.
6
Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.尿糖胺聚糖被选择性地纳入从全人类尿液中沉淀出的草酸钙晶体中。
Scanning Microsc. 1994;8(3):523-30.
7
Glycosaminoglycans in crystal-surface binding substances and their role in calcium oxalate crystal growth.晶体表面结合物质中的糖胺聚糖及其在草酸钙晶体生长中的作用。
Br J Urol. 1997 Jul;80(1):64-8. doi: 10.1046/j.1464-410x.1997.00189.x.
8
[Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer].[使用凝集仪研究尿大分子对草酸钙晶体聚集的抑制活性]
Nihon Hinyokika Gakkai Zasshi. 1993 Feb;84(2):339-44. doi: 10.5980/jpnjurol1989.84.339.
9
Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.白蛋白介导的草酸钙晶体成核作用:对预防结石形成的影响。
Kidney Int. 1999 May;55(5):1776-86. doi: 10.1046/j.1523-1755.1999.00426.x.
10
Modulators of urinary stone formation.尿路结石形成的调节剂。
Front Biosci. 2004 May 1;9:1450-82. doi: 10.2741/1347.

引用本文的文献

1
In situ flow cell platform for examining calcium oxalate and calcium phosphate crystallization on films of basement membrane extract in the presence of urinary 'inhibitors'.用于在存在尿液“抑制剂”的情况下检测草酸钙和磷酸钙在基底膜提取物膜上结晶的原位流动池平台。
CrystEngComm. 2020 Feb 28;22(8):1448-1458. doi: 10.1039/c9ce01587f. Epub 2020 Feb 5.
2
Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.肾结石:肾结石形成的分子机制和调节剂的关键作用。
Biomed Res Int. 2013;2013:292953. doi: 10.1155/2013/292953. Epub 2013 Sep 14.
3
Protective role of heparin/heparan sulfate on oxalate-induced changes in cell morphology and intracellular Ca2+.

本文引用的文献

1
The composition, structure, and mechanisms of the formation of urinary calculi.尿结石的组成、结构及形成机制。
Br J Urol. 1962 Jun;34:129-59. doi: 10.1111/j.1464-410x.1962.tb06505.x.
2
A modified uronic acid carbazole reaction.一种改良的糖醛酸咔唑反应。
Anal Biochem. 1962 Oct;4:330-4. doi: 10.1016/0003-2697(62)90095-7.
3
Stone matrix and mucoprotein from urine.来自尿液的结石基质和粘蛋白。
肝素/硫酸乙酰肝素对草酸盐诱导的细胞形态和细胞内钙离子变化的保护作用。
Urol Res. 2003 Jul;31(3):198-206. doi: 10.1007/s00240-003-0317-2. Epub 2003 Apr 29.
4
Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.对正常受试者和草酸钙结石形成者经标准化体积调整的12小时夜间尿液中的尿液成分及钙盐结晶特性进行评估。
Urol Res. 1997;25(5):365-72. doi: 10.1007/BF01294667.
5
Expression of heparan sulfate proteoglycan mRNA in rat kidneys during calcium oxalate nephrolithiasis.草酸钙肾结石形成过程中大鼠肾脏硫酸乙酰肝素蛋白聚糖mRNA的表达
Urol Res. 1997;25(5):361-4. doi: 10.1007/BF01294666.
6
Characterization of protein components of human urinary crystal surface binding substance.人尿晶体表面结合物质的蛋白质成分表征
Urol Res. 1997;25(5):355-60. doi: 10.1007/BF01294665.
7
Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.草酸钙结晶的尿中抑制剂及其在结石形成中的潜在作用。
World J Urol. 1997;15(3):155-64. doi: 10.1007/BF02201852.
8
Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.糖胺聚糖、蛋白质与结石形成:成人话题与儿童游戏
Pediatr Nephrol. 1996 Oct;10(5):656-66. doi: 10.1007/s004670050185.
9
Glycosaminoglycans and other sulphated polysaccharides in calculogenesis of urinary stones.糖胺聚糖及其他硫酸化多糖在尿路结石形成过程中的作用
World J Urol. 1994;12(1):43-8. doi: 10.1007/BF00182050.
J Urol. 1961 Oct;86:355-63. doi: 10.1016/S0022-5347(17)65178-4.
4
Inhibitory effects of urinary calcium-binding substances on calcium oxalate crystallization.
J Urol. 1982 Mar;127(3):568-71. doi: 10.1016/s0022-5347(17)53913-0.
5
Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?结石形成者的尿液中是否含有能在体外促进草酸钙晶体生长速率的大分子?
Clin Chim Acta. 1980 Nov 20;108(1):75-80. doi: 10.1016/0009-8981(80)90294-6.
6
Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.尿中大分子物质作为草酸钙晶体聚集的天然抑制剂。
Invest Urol. 1981 Mar;18(5):382-6.
7
Organic matrix of human urinary concretions.人类尿结石的有机基质。
Am J Med. 1968 Nov;45(5):673-83. doi: 10.1016/0002-9343(68)90203-9.
8
Mechanisms of genesis and growth of calculi.结石的形成与生长机制。
Am J Med. 1968 Nov;45(5):684-92. doi: 10.1016/0002-9343(68)90204-0.
9
Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro.草酸钙晶体在体外生长和聚集的抑制剂。
Clin Chim Acta. 1973 Jan 10;43(1):31-7. doi: 10.1016/0009-8981(73)90114-9.
10
A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis.一种通过二维电泳分离酸性糖胺聚糖的快速微量方法。
Anal Biochem. 1972 Feb;45(2):462-8. doi: 10.1016/0003-2697(72)90208-4.